• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans

tetano

Editor, Senior Moderator
Sci Rep


. 2026 May 19;16(1):15479.
doi: 10.1038/s41598-026-47568-6.
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans

Fabian Heinrich[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Jöran Lücke[SUP] #[/SUP][SUP] 4 5 6 [/SUP], Siwen Zhang[SUP] 4 5 [/SUP], Morsal Sabihi[SUP] 4 5 [/SUP], Christian Bernreuther[SUP] 7 [/SUP], Katja Giersch[SUP] 8 [/SUP], Lena Allweiss[SUP] 9 10 [/SUP], Kristin Hartmann[SUP] 11 [/SUP], Edda Thies[SUP] 11 [/SUP], Philine Lange[SUP] 12 [/SUP], Jakob Matschke[SUP] 11 [/SUP], Anja A Kühl[SUP] 13 [/SUP], Ronja Mothes[SUP] 14 [/SUP], Helena Radbruch[SUP] 14 [/SUP], Ann Sophie Schröder[SUP] 12 [/SUP], Axel Heinemann[SUP] 12 [/SUP], Maura Dandri[SUP] 9 [/SUP], Martin Aepfelbacher[SUP] 8 [/SUP], Samuel Huber[SUP] 4 5 [/SUP], Anastasios Giannou[SUP] 4 5 6 [/SUP], Markus Glatzel[SUP] 11 [/SUP], Benjamin Ondruschka[SUP] 12 [/SUP], Marc Lütgehetmann[SUP] 8 [/SUP], Susanne Krasemann[SUP] 15 [/SUP]


Affiliations
Free article Abstract

Since the emergence of the COVID-19 pandemic, the successful distribution and application of mRNA vaccines have helped to contain the spread of SARS-CoV-2 and saved countless lives worldwide. mRNA vaccines are not only being developed and tested for infectious diseases, but also for numerous new applications, such as cancer therapy. Although the general mechanisms of mRNA vaccinations have been thoroughly studied, data regarding the local anatomical distribution after vaccination have been scarce. Here, we investigated the spatiotemporal distribution of BNT162b2 and mRNA-1273 vaccines in mice and deceased humans. We found that vaccine-related mRNA and spike protein could be detected at the vaccination site of patients and mice, with muscle-associated fibroblasts being a major source of spike protein expression. In contrast, we did not detect expression of vaccine-related spike protein in immune cells at the injection site. While mRNA-vaccine-related mRNA or spike protein could not be detected in extramuscular organs in humans in our study, it was detected in several organs in mice, even up to 7 days after initial vaccination. Together, these data enhance our understanding of mRNA vaccine kinetics and distribution patterns, providing valuable insights to guide scientists in refining future mRNA vaccine-based therapies whenever appropriate.

Keywords: COVID-19; SARS-CoV-2; Spatiotemporal distribution; Vaccination; mRNA vaccine.

 
Back
Top